Record Point is an independent corporate advisory firm specialising in domestic and international advisory services for public and private companies.

Record Point advises GenesisCare on its sale of CardioCo to Adamantem Capital

GenesisCare, the largest provider of integrated cancer care globally and cardiology services in Australia, announced Australian based investment manager Adamantem Capital as its new investment partner for its cardiology services network ‘CardioCo’.

With Adamantem’s new investment, CardioCo will demerge from the GenesisCare network upon completion of the transaction to become Australia’s premier standalone cardiology services provider.

CardioCo has a network of more than 100 private practices and a team of 100+ cardiologists and respiratory physicians, and 700+ technicians and support staff. CardioCo’s doctors and support teams deliver vital cardiology services to more than 200,000 patients each year across metropolitan, regional, and remote Australia.

Coinciding with the transaction, CardioCo is expected to extend its footprint with the acquisition of a thriving cardiology practice in Sydney. CardioCo will also form a strategic partnership with Australia’s leading provider of outsourced cardiac diagnostic and remote monitoring services, CardioNexus, as part of its long-term plan to invest in end-to-end diagnostic cardiac services.

Record Point acted as financial advisor to GenesisCare.